Biotech ETF Trending Shows Shift To Speculative Stocks: XBI

Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well.
Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc
Rapid Fire Re-Balancing of ETFs into More Speculative Names
Is the Tail Wagging the Dog?
We have published a number of reports on Life Science ETFs (2/4/15) in the past and noticed changes lately that reflect a […]

Has Biotech Turned the Corner?

The mixed close Tuesday further clouds the short-term market outlook as it suggests the correction from last week’s highs may not yet be over. A drop in the market tracking ETFs below last Friday’s lows will indicate a decline to more important support. The S&P futures are down in early trading and the heavy selling last week identifies that key […]

The 5 hottest ETFs in the world

Biotech companies are restoring sight to the blind, curing hepatitis C and fighting off HIV.As they save lives, biotech companies are simultaneously making a lot of money for investors.That’s why the hottest ETFs (exchange-traded funds) on the planet since the bull market began in March 2009 invest in biotech companies.The First Trust NYSE Arca Biotech ETF (FBT) has skyrocketed more […]

3 Biotech ETFs Rally On Merger News

View photo.The biotech stocks are hitting fresh new highs to start the week after the announcement of yet another multi-billion dollar deal. Pharmaceutical giant Merck & Co., Inc. (NYSE: MRK) has agreed to purchase advanced antibiotic pharmaceutical company Cubist Pharmaceuticals Inc (NASDAQ: CBST) for $9.5 billion.The deal breaks down to Merck paying about $102 a share, a 37-percent premium from […]